Sound Bioventures
Investor profile
Venture capital
Sound Bioventures has backed 4 European tech companies across 6 funding rounds between 2022 and 2026, joining rounds totalling €238M. Most active in Healthtech. Data as of Nov 2026.
Deals
6
distinct rounds
Companies
4
backed
Active span
2022–2026
5 yrs
Total round €
€238M
sum of rounds joined
Deals by year
distinct rounds / yearSound Bioventures — deals by year — interactive chart.
Data table
| Sound Bioventures — deals by year | |
|---|---|
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Top sectors
by dealsSound Bioventures — top sectors — interactive chart.
Data table
| Sound Bioventures — top sectors | |
|---|---|
| Healthtech | 6 |
Stages
by dealsSound Bioventures — stages — interactive chart.
Data table
| Sound Bioventures — stages | |
|---|---|
| Series B | 4 |
| Seed | 1 |
| Series A | 1 |
Countries
by dealsSound Bioventures — countries — interactive chart.
Data table
| Sound Bioventures — countries | |
|---|---|
| Denmark | 2 |
| Spain | 2 |
| Netherlands | 1 |
| Sweden | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- European Innovation Council (EIC)3
- Novo Holdings3
- AdBio partners2
- Columbus Venture Partners2
- Hadean Ventures2
- Innovestor Life Science Fund2
- Invivo Capital Partners2
- Ljungström family office2
- Bpifrance1
- Catalyze Capital1
- CDTI Innovación (Innvierte)1
- Centre for the Development of Industrial Technology (CDTI)1
- EIFO1
- Flerie Invest1
- Helsinn Investment Fund1
- Industrifonden1
- LLD Nybohov Invest AB1
- Mission BioCapital1
- Modi Ventures1
- Pappas Capital1
- Pureos Bioventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Arthex Biotech | Spain | 2 | €74M |
| Breye Therapeutics | Denmark | 2 | €72M |
| AnaCardio | Sweden | 1 | €63M |
| VarmX | Netherlands | 1 | €30M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Arthex Biotech | Series B | €42M | 2023-05 |
| Arthex Biotech | Series B | €32M | 2025-09 |
| VarmX | Series B | €30M | 2023-05 |
| Breye Therapeutics | Seed | €4.0M | 2022-11 |